📢New Special Issue Open: "Targeted #Radionuclide Therapy in the #Theranostics Era" warmly welcoming new submissions. ✏️Guest editor: Dr. Carlo Aprile & Dr. Lorenzo Lodola 🔗https://lnkd.in/geb6VzqT
Advances in Radiotherapy & Nuclear Medicine’s Post
More Relevant Posts
-
Why is ethnic diversity essential in clinical trials? Diverse participants represent varied genetic, environmental, and cultural factors that can impact treatment outcomes. In our blog, we explore how clinical trials achieve diversity through the running of multi-national global clinical trials. Discover the significance of diversity in precision medicine. https://lnkd.in/gx4-RaaH #InclusiveTrials #EthnicDiversity #MedicalAdvancements #HealthcareEquality #ClinicalStudy
To view or add a comment, sign in
-
New publication: Functional neuroimaging in patients with catatonia: A systematic review https://lnkd.in/gH_7cXem
To view or add a comment, sign in
-
Delving deeper into our exploration of the clinical trials landscape in 2023 (Part 2): 🔍 Examining clinical trial activity per intervention category, we unravel the overall top 10 🏅, witness categories with remarkable year-by-year growth 🚀, and delve into the categories experiencing a notable decline 📉 in activity. These highlights not only capture the statistical increases and reductions but also paint a vivid picture of the diverse and evolving landscape of medical interventions, from the intricate world of genetics to the nuanced realm of behavioural health. #ClinicalTrials #ResearchTrends #2023InReview
To view or add a comment, sign in
-
Learn more about novel geographic atrophy therapy. In this article, experts discuss how AVD-104 has shown efficacy in GA patients, including visual improvement, with an excellent safety profile. Read here: https://bit.ly/3TTZTIq
To view or add a comment, sign in
-
Coming up in the next edition of Asian Journal of Medical Sciences #Stress #hyperglycemia #prognostic #indicator #clinical #Outcome #ischemic #stroke #OpenAccess #peerreviewed #publicationaheadoftime #asianjournalofmedicalsciences
To view or add a comment, sign in
-
“Our hope is that with a validated device for use in narcolepsy, we can contribute to limiting the burden of traveling to a sleep center. Beyond the clinical trial setting, a validated Digital Health Tool could help to improve the diagnostic journey by allowing for a timely differential diagnosis for people living with narcolepsy.” So exciting to see this initiative to pair the development of a therapeutic innovation with digital innovation to add more value for patients living with narcolepsy.
In a Q&A with Clinical Leader, Elena Koundourakis, head of the Orexin franchise development and neuroscience portfolio strategy, explains why Takeda is exploring the use of digital health tools with Beacon Biosignals to support future clinical development and diagnosis of narcolepsy. Read more here: https://lnkd.in/eVQb-Fer #WhereScienceis #WhereScienceIsDigital
To view or add a comment, sign in
-
Clinical trial for provoked vestibulodynia (PVD) have inconsistent outcomes, hindering comparison. New study defined a core outcome set (COS) for PVD, including pain and sexual function, to standardize future research and improve treatment recommendations: https://lnkd.in/gtrMhzBC
To view or add a comment, sign in
-
A mouse is not a human, and dialysis is not a kidney. Researchers from Sangeeta Bhatia, Christopher Chen, David Mooney, and Jennifer Lewis' labs are all part of the Wellcome Leap initiative. As part of the HOPE program, they worked to pioneer new solutions to the organ donor shortage and create better platforms to predict human immune responses to drugs. Take a glimpse into the stories of various researchers working as part of this effort. Together, we're challenging the notion of what's possible to achieve. https://lnkd.in/exesscfr #WellcomeLeap #Collaboration #OrganDonorShortage #KidneyDisease
To view or add a comment, sign in
-
📢 We have a new Science letter! 📢 Ion channels are imperative to the normal functioning of the cell. Find out their key roles and potential as promising targets in pathologies, in this letter by Dr. Christophe Vandier. https://lnkd.in/dbSkKeM7 #sciencenews #lifesomenews #ionchannels
News | Lifesome Therapeutic
lifesometherapeutics.com
To view or add a comment, sign in
569 followers